Inside a Canadian biotech firm’s fight to prove ‘stock spoofing’ - Part 3

Key Concepts

• Multiple Sclerosis (MS): A chronic, autoimmune disease affecting the central nervous system.
• Lucid MS: A drug developed by Quantum Bioarma targeting a specific mechanism for MS treatment.
• Stock Manipulation: Illegally influencing the price of a stock for personal gain.
• Spoofing: A specific stock manipulation tactic involving placing large buy or sell orders with no intention of executing them, to mislead other traders about price direction.
• NASDAQ: A major stock exchange in New York City.

Lucid MS and Quantum Bioarma's Potential Breakthrough

Dr. Andre Kuchinsk's team, located east of Toronto, is working on a novel treatment for multiple sclerosis (MS) called Lucid MS, developed by Quantum Bioarma. This drug targets a unique mechanism, with no other existing treatments addressing the same pathway. The company's founder and president, Anthony Durkatch, highlighted the drug's potential through a video demonstrating its effect on mice. The video shows a mouse that had lost its ability to walk regaining mobility after receiving the drug, suggesting a significant therapeutic impact.

Investor Concerns and Stock Performance

Anthony Durkatch initially intended to raise capital for clinical trials by seeking investment from stock markets in Toronto and New York. He believed in the "very big potential" of Lucid MS. However, investor experiences have been negative. For instance, an investor named Ahmed reportedly invested approximately $100,000 in Quantum Bioarma shares, expecting it to secure his retirement, but the stock value subsequently declined significantly, being "almost wiped out." This drastic drop led investors to suspect that "something was wrong."

Discovery of Stock Manipulation: Spoofing

In response to the stock's performance, Quantum Bioarma began a detailed examination of its trading data. The company primarily trades on the NASDAQ exchange in New York City. During their analysis, they identified an unusual pattern: millions of trades that were ordered but never completed. These unfulfilled orders, often occurring within seconds, appeared to be strategically placed to drive the stock price downwards.

Explanation of Stock Spoofing

Quantum Bioarma's investigation revealed a stock manipulation tactic known as "spoofing." This practice involves a trader placing substantial buy or sell orders with the explicit intention of never executing them. The purpose of these fake orders is to deceive other investors about the true direction of the stock price.

Analogy for Spoofing: The transcript uses an analogy to explain spoofing: "It's like pretending to order lots of pizzas just to convince other customers the market for pizza is hot, the price is going up, and then cancelling all of those orders and making money by selling the pizza you already own." In the context of stock trading, the "sale orders are there as a mask to try to push the share price lower."

Conclusion and Main Takeaways

The video transcript details Quantum Bioarma's promising MS drug, Lucid MS, and the subsequent financial distress experienced by its investors due to a significant decline in stock value. The company's investigation uncovered evidence of stock manipulation, specifically spoofing, on the NASDAQ exchange. This tactic, involving the placement of non-genuine large orders, was used to artificially depress the stock price, causing substantial losses for investors like Ahmed. The core issue highlighted is the impact of illicit trading practices on legitimate investment and the development of potentially life-changing medical treatments.